A circulating MicroRNA profile is associated with late- stage neovascular age-related macular degeneration

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Grassmann, Felix ^a   Schoenberger, Peter G A ^a   Brandl, Caroline ^a,b   Schick, Tina ^c   Hasler, Daniele ^a   Meister, Gunter ^a   Fleckenstein, Monika ^d   Lindner, Moritz ^d   Helbig, Horst ^b   Fauser, Sascha ^c   Weber, Bernhard H F ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HSA MICRORNA 301 3P; HSA MICRORNA 361 5P; HSA MICRORNA 424 5P; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; TRANSCRIPTOME;

AGE RELATED MACULAR DEGENERATION; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENOTYPE; GEOGRAPHIC ATROPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PREDICTION; RETINA NEOVASCULARIZATION; RNA REPLICATION; SENSITIVITY AND SPECIFICITY; BLOOD; CASE CONTROL STUDY; EXOSOME; GENETICS; MACULAR DEGENERATION; PROCEDURES; RISK; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; EXOSOMES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MACULAR DEGENERATION; MALE; MICRORNAS; RISK; TRANSCRIPTOME;

EID: 84929940103     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107461     Document Type: Article

References (37)

1. Swaroop A, Branham KE, Chen W, Abecasis G (2007) Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. Hum Mol Genet 16 Spec No: R174-82.
2. Fritsche LG, Fariss RN, Stambolian D, Abecasis GR, Curcio CA, et al. (2014) Age-Related Macular Degeneration: Genetics and Biology Coming Together. Annu Rev Genomics Hum Genet.
3. Jonasson F, Arnarsson A, Eiríksdottir G, Harris TB, Launer LJ, et al. (2011) Prevalence of age-related macular degeneration in old persons: Age, Gene/ environment Susceptibility Reykjavik Study. Ophthalmology 118: 825-830.
4. Friedman DS, O'Colmain BJ, Muñoz B, Tomany SC, McCarty C, et al. (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122: 564-572.
5. VanNewkirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR, et al. (2000) The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 107: 1593-1600.
6. Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, et al. (2004) Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 111: 1280-1287.
7. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC (2005) The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123: 321-327.
8. Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, et al. (2013) Seven new loci associated with age-related macular degeneration. Nat Genet 45: 433-9, 439e1-2.
9. Grassmann F, Fritsche LG, Keilhauer CN, Heid IM, Weber BHF (2012) Modelling the genetic risk in age-related macular degeneration. PLoS One 7: e37979.
10. Gallo A, Tandon M, Alevizos I, Illei GG (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7: e30679.
11. Turchinovich A, Weiz L, Burwinkel B (2012) Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci 37: 460-465.
12. Zhang Y, Liu D, Chen X, Li J, Li L, et al. (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39: 133-144.
13. Lässer C (2012) Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors. Expert Opin Biol Ther 12 Suppl 1: S189-97.
14. Kanitz A, Imig J, Dziunycz PJ, Primorac A, Galgano A, et al. (2012) The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma. PLoS One 7: e49568.
15. Hu Z, Chen X, Zhao Y, Tian T, Jin G, et al. (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28: 1721-1726.
16. Cohen J (1988) Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates.
17. Yu Y, Bhangale TR, Fagerness J, Ripke S, Thorleifsson G, et al. (2011) Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet 20: 3699-3709.
18. Leveziel N, Puche N, Richard F, Somner JEA, Zerbib J, et al. (2010) Genotypic influences on severity of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 51: 2620-2625.
19. Klein ML, Ferris FL, Francis PJ, Lindblad AS, Chew EY, et al. (2010) Progression of geographic atrophy and genotype in age-related macular degeneration. Ophthalmology 117: 1554-9, 1559.e1.
20. Zhao H, Wang J, Gao L, Wang R, Liu X, et al. (2013) MiRNA-424 Protects Against Permanent Focal Cerebral Ischemia Injury in Mice Involving Suppressing Microglia Activation. Stroke 44: 1706-1713.
21. Koh JT, Zheng J (2007) The new biomimetic chemistry: artificial transcription factors. ACS Chem Biol 2: 599-601.
22. Hagan EL, Banaszynski LA, Chen L, Maynard-Smith LA, Wandless TJ (2009) Regulating protein stability in mammalian cells using small molecules. Cold Spring Harb Protoc 2009: pdb.prot5172.
23. Scott AW, Bressler SB (2013) Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration. Curr Opin Ophthalmol 24: 190-196.
24. Ferris FL, Davis MD, Clemons TE, Lee L-Y, Chew EY, et al. (2005) A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 123: 1570-1574.
25. Ristau T, Paun C, Ersoy L, Hahn M, Lechanteur Y, et al. (2014) Impact of the Common Genetic Associations of Age-Related Macular Degeneration upon Systemic Complement Component C3d Levels. PLoS One 9: e93459.
26. Dreyhaupt J, Mansmann U, Pritsch M, Dolar-Szczasny J, Bindewald A, et al. (2005) Modelling the natural history of geographic atrophy in patients with agerelated macular degeneration. Ophthalmic Epidemiol 12: 353-362.
27. Köberle V, Pleli T, Schmithals C, Alonso EA, Haupenthal J, et al. (2013) Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers. 8: 1-11.
28. Kosaka N, Izumi H, Sekine K, Ochiya T (2010) microRNA as a new immuneregulatory agent in breast milk. Silence 1: 7.
29. Friedlaender MR, Chen W, Adamidi C, Maaskola J, Einspanier R, et al. (2008) Discovering microRNAs from deep sequencing data using miRDeep. Nat Biotechnol 26: 407-415.
30. Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118-127.
31. Hurteau GJ, Spivack SD, Brock GJ (2006) Potential mRNA degradation targets of hsa-miR-200c, identified using informatics and qRT-PCR. Cell Cycle 5: 1951-1956.
32. R Core Team (2013). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at http:// www.R-project.org/.
33. Lu T-P, Lee C-Y, Tsai M-H, Chiu Y-C, Hsiao CK, et al. (2012) miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets. PLoS One 7: e42390.
34. Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, et al. (2012) DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res 40: W498-504.
35. Virasakdi Chongsuvivatwong (2012). epicalc: Epidemiological calculator. R package version 2.15.1.0. Available at http://CRAN.R-project.org/ package= epicalc.
36. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, et al. (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324: 1710-1713.
37. Carpentier G, Martinelli M, Courty J, Cascone I (2012) Angiogenesis Analyzer for ImageJ. 4th ImageJ User and Developer Conference proceedings, 198-201, Mondorf-les-Bains, Luxembourg, ISBN 2-919941-18-6.